Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study
Authors:
- Georg BrabantGBGeorg Brabant
- Alexander von Zur MühlenAMAlexander von Zur Mühlen
- Christian WüsterCWChristian Wüster
- Michael B. RankeMRMichael B. Ranke
- Jürgen KratzschJKJürgen Kratzsch
- Wieland KiessWKWieland Kiess
- Jean-Marie KetelslegersJKJean-Marie Ketelslegers
- Lars WilhelmsenLWLars Wilhelmsen
- Lena HulthénLHLena Hulthén
- Bernhard SallerBSBernhard Saller
- Anders MattssonAMAnders Mattsson
- Jürgen WildeJWJürgen Wilde
Open Access
- 1 July 2003
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 60 (2) , 53-60
Abstract
Background: Analysis of insulin-like growth factor I in serum (S-IGF-I) is an integral component in the diagnosis of GH-related disorders and is going to be of interest in the diagnosis and follow-up of many disorders. The objective of the present study was to develop cross-sectional reference values for S-IGF-I measured by an automated chemiluminescence immunoassay (Nichols Advantage®). Methods: The study included samples from 3,961 healthy subjects (2,201 males, 1,760 females) aged 1 month to 88 years. Six laboratories were involved in this study and the samples were analyzed by one of seven automated immunoassay systems run in these laboratories. For data analysis, polynomial age and sex-specific models were fitted after transformation of S-IGF-I values. Results: The results show the well-known age dependency of S-IGF-I levels. At ages Conclusion: The present study establishes age- and sex-specific reference values for a fully automated immunoassay system based on a large population of healthy subjects. The established reference values may be used for this immunoassay system in different laboratories provided that the systematic difference between systems is low.Keywords
This publication has 12 references indexed in Scilit:
- Reference Values for IGF-I throughout Childhood and Adolescence: A Model that Accounts Simultaneously for the Effect of Gender, Age, and PubertyThe Journal of Clinical Endocrinology & Metabolism, 2001
- E2 Supplementation Selectively Relieves GH's Autonegative Feedback on GH-Releasing Peptide-2-Stimulated GH SecretionThe Journal of Clinical Endocrinology & Metabolism, 2001
- Optimizing GH Therapy in Adults and ChildrenEndocrine Reviews, 2001
- Insulin-like growth factor 1 measurement in diagnosis and management of acromegalyAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2001
- Normal Values of Insulin-Like Growth Factor I and Their Clinical Utility in AdultsHormone Research in Paediatrics, 2001
- Consensus Guidelines for the Diagnosis and Treatment of Growth Hormone (GH) Deficiency in Childhood and Adolescence: Summary Statement of the GH Research SocietyThe Journal of Clinical Endocrinology & Metabolism, 2000
- Serum Levels of Insulin-Like Growth Factor I in 152 Patients with Growth Hormone Deficiency, Aged 19-82 Years, in Relation to Those in Healthy SubjectsThe Journal of Clinical Endocrinology & Metabolism, 1999
- Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 1998
- Free Insulin-Like Growth Factor I Serum Levels in 1430 Healthy Children and Adults, and Its Diagnostic Value in Patients Suspected of Growth Hormone DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 1997
- Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing childrenThe Journal of Clinical Endocrinology & Metabolism, 1996